Trobalt यूरोपीय संघ - स्लोवेनियाई - EMA (European Medicines Agency)

trobalt

glaxo group limited  - retigabin - epilepsija - antiepileptics, - zdravilo trobalt je indicirano kot dodatno zdravljenje epileptičnih napadov z odpornimi proti drogam s sekundarno generalizacijo ali brez nje pri bolnikih, starih 18 let ali več, pri katerih so se druge primerne kombinacije zdravil izkazale za neustrezne ali niso bile tolerirane.

Ontozry यूरोपीय संघ - स्लोवेनियाई - EMA (European Medicines Agency)

ontozry

angelini pharma s.p.a - cenobamate - epilepsija - antiepileptics, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.

Ztalmy यूरोपीय संघ - स्लोवेनियाई - EMA (European Medicines Agency)

ztalmy

marinus pharmaceuticals emerald limited - ganaxolone - epileptic syndromes; spasms, infantile - drugi antiepileptics - ztalmy is indicated for the adjunctive treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (cdkl5) deficiency disorder (cdd) in patients 2 to 17 years of age. ztalmy may be continued in patients 18 years of age and older.